Financial writer covers the acquisition of Amedisys, Inc. by UnitedHealth Group. Click to see whether the deal is likely to go through and more on UNH and AMED.

UnitedHealth outbid several competitors to scoop up Amedisys, with the deal first coming to light in late June 2023. Should ...

UnitedHealth (UNH) and Amedisys (NASDAQ:AMED) are expected to meet with Dept. of Justice officials in a final effort to ...

UnitedHealth Group Inc. and Amedisys Inc. representatives are slated to meet with top Justice Department antitrust enforcers ...

Amedisys (Nasdaq: AMED) and UnitedHealth Group (NYSE: UNH) leaders were reportedly set to meet with officials from the U.S. Department of Justice (DOJ) ...

UnitedHealth Group (NYSE: UNH) and Amedisys (Nasdaq: AMED) leaders are reportedly expected to meet with officials from the ...

Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Amedisys (AMED) and Chemed (CHE). But which of these two companies is the best ...

UnitedHealth Group Inc. and Amedisys Inc. representatives are slated to meet with top Justice Department antitrust enforcers in a last-ditch effort to persuade the agency not to challenge their ...

A stock is considered to be oversold if the RSI reading falls below 30. In trading on Thursday, shares of Amedisys, Inc. (Symbol: AMED) entered into oversold territory, hitting an RSI reading of ...

After more than three decades in the business, Gwendolyn Puryear is hanging up her home health hat. Puryear has spent nearly ...

Quest Diagnostics, Encompass Health, Amedisys and Addus HomeCare have been highlighted in this Industry Outlook article.

UnitedHealth (UNH) and Amedisys (NASDAQ:AMED) are expected to meet with Dept. of Justice officials in a final effort to persuade the agency to not file a lawsuit to block its proposed deal.